SaNOtize Nasal Spray Wins Approval As Early Treatment Option For COVID-19
While other global approvals were were focused on prevention, this is the first approval for SaNOtize nasal spray as early treatment for COVID-19.
February 23, 2022
SaNOtize Receives Approval To Sell Its Anti-COVID Nasal Spray In India
Glenmark Pharmaceuticals will manufacture the spray in India and intends to produce, market and distribute it to other Asian countries.
February 13, 2022
SaNOtize Ramps Up Anti-COVID Nasal Spray Production To Keep Up With Demand
SaNOtize is increasing production in Israel and beyond as it attempts to keep up with international demand for its Enovid nasal spray.
November 30, 2021
SaNOtize To Launch Anti-COVID Nasal Spray In India, Asian Markets
SaNOtize signed a deal with India's Glenmark Pharmaceuticals to market and sell their Nitric Oxide Nasal Spray (NONS) in India, Vietnam, and more.
August 03, 2021
SaNOtize Rolls Out Anti-COVID Nasal Spray In Israel, Bahrain
Enovid, SaNOtize’s Nitric Oxide Nasal Spray (NONS), will be sold in Israel after receiving emergency use authorization as a medical device by the Ministry of Health.
July 15, 2021